Skip to Main Content

Author Details

Kate M Herum
KG Jebsen Center for Cardiac Research, University of Oslo
2013
18
14
PMIDPaper TitleJournal TitlePublished Year
35522553Integrin α11β1 and syndecan-4 dual receptor ablation attenuate cardiac hypertrophy in the pressure overloaded heart.Am J Physiol Heart Circ Physiol2022
35719864Cardiac fibroblast sub-types <i>in vitro</i> reflect pathological cardiac remodeling <i>in vivo</i>.Matrix Biol Plus2022
35626694Fibrotic Signaling in Cardiac Fibroblasts and Vascular Smooth Muscle Cells: The Dual Roles of Fibrosis in HFpEF and CAD.Cells2022
33104742Maintaining resting cardiac fibroblasts in vitro by disrupting mechanotransduction.PLoS One2020
32000579Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin.J Am Heart Assoc2020
29337052Sweet, yet underappreciated: Proteoglycans and extracellular matrix remodeling in heart disease.Matrix Biol2019
30850523Array atomic force microscopy for real-time multiparametric analysis.Proc Natl Acad Sci U S A2019
30847799Cancer-associated fibroblasts: how do they contribute to metastasis?Clin Exp Metastasis2019
28771943Overexpression of integrin α11 induces cardiac fibrosis in mice.Acta Physiol (Oxf)2018
28534817The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart.J Clin Med2017
28468977Mechanical regulation of cardiac fibroblast profibrotic phenotypes.Mol Biol Cell2017
27411689Syndecans in heart fibrosis.Cell Tissue Res2016
27768722The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 Signaling.PLoS One2016
25587045Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart.Cardiovasc Res2015
25694587Lack of collagen VIII reduces fibrosis and promotes early mortality and cardiac dilatation in pressure overload in mice.Cardiovasc Res2015
24561864Downregulation of L-type Ca2+ channel in rat mesenteric arteries leads to loss of smooth muscle contractile phenotype and inward hypertrophic remodeling.Am J Physiol Heart Circ Physiol2014
23374111Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart.FEBS J2013
23178899Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress.J Mol Cell Cardiol2013
  • 1 - 18 of 18

Recommended Authors

University of Virginia
Career Start Year 2018
Number of shared co-authors 1
The Second Xiangya Hospital, Central South University
Career Start Year 2017
Number of shared co-authors 0
University of Alabama at Birmingham, 1670 University Boulevard
Career Start Year 2016
Number of shared co-authors 0
University of California at Davis
Career Start Year 2013
Number of shared co-authors 0
Humanitas Clinical and Research Center-IRCCS
Career Start Year 2009
Number of shared co-authors 1
Wyss Institute for Biologically Inspired Engineering, Harvard University
Career Start Year 2008
Number of shared co-authors 1
Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 0
Second Affiliated Hospital of Harbin Medical University
Career Start Year 2004
Number of shared co-authors 0
Gladstone Institutes San Francisco
Career Start Year 2004
Number of shared co-authors 0
Novartis Institutes for BioMedical Research, Inc. Cambridge
Career Start Year 2003
Number of shared co-authors 0
University of Virginia
Career Start Year 2003
Number of shared co-authors 1
university of california los angeles
Career Start Year 2002
Number of shared co-authors 0
Medical University of Graz
Career Start Year 2001
Number of shared co-authors 0
Baker Heart and Diabetes Institute
Career Start Year 1998
Number of shared co-authors 0
Maastricht University Medical Centre
Career Start Year 1998
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1998
Number of shared co-authors 1
Albert Einstein College of Medicine
Career Start Year 1997
Number of shared co-authors 0
University of Toronto, University Avenue
Career Start Year 1996
Number of shared co-authors 0
University of Twente
Career Start Year 1995
Number of shared co-authors 0
National Rehabilitation Center for Persons with Disabilities
Career Start Year 1994
Number of shared co-authors 0
University of California los angeles
Career Start Year 1993
Number of shared co-authors 0
University of Washington
Career Start Year 1993
Number of shared co-authors 0
Institute for Precision Cardiovascular Medicine
Career Start Year 1992
Number of shared co-authors 0
Boston Children's Hospital, Harvard Medical School
Career Start Year 1989
Number of shared co-authors 0
Gladstone Institutes San Francisco
Career Start Year 1989
Number of shared co-authors 0
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 0
Center for Molecular Medicine, Maine Medical Center Research Institute
Career Start Year 1985
Number of shared co-authors 0
Beth Israel Deaconess Medical Center.
Career Start Year 1984
Number of shared co-authors 0
University of Virginia School of Medicine
Career Start Year 1982
Number of shared co-authors 0

Collaborators

University of California
Co-authored papers 5
University of California San Diego
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Rice University, University of California San Diego
Co-authored papers 1
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of California
Co-authored papers 1